To show that VTD‐dependent reduction in mot‐2 does not only occur in well‐differentiated colon cancer cells, we repeated the VTD experiments in HCT‐116 cells, a highly metastatic colon cancer cell line (Li and Chen, 2010). This evidence concerns the gene HSPA9 and colonic neoplasm.